150 related articles for article (PubMed ID: 28984383)
1. Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.
Deguchi M; Kagita M; Yoshioka N; Tsukamoto H; Takao M; Tahara K; Maeda I; Hidaka Y; Yamauchi S; Kaneko A; Miyakoshi H; Isomura M
J Clin Lab Anal; 2018 May; 32(4):e22334. PubMed ID: 28984383
[TBL] [Abstract][Full Text] [Related]
2. Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.
Shinkai N; Matsuura K; Sugauchi F; Watanabe T; Murakami S; Iio E; Ogawa S; Nojiri S; Joh T; Tanaka Y
J Clin Microbiol; 2013 Nov; 51(11):3484-91. PubMed ID: 23946517
[TBL] [Abstract][Full Text] [Related]
3. [Development of Highly Sensitive Quantitative HBsAg Reagent and Its Availability].
Moriyama K; Isomura M
Rinsho Byori; 2015 Jan; 63(1):44-52. PubMed ID: 26524878
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.
Yang L; Song LW; Fang LL; Wu Y; Ge SX; Li H; Yuan Q; Zhang J; Xia NS
J Virol Methods; 2016 Feb; 228():55-9. PubMed ID: 26615806
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of a newly developed high-sensitive detection of hepatitis B virus surface antigen by a semi-automated immune complex transfer chemiluminescent enzyme immunoassay].
Ohne K; Kani S; Ohashi M; Shinkai N; Inoue T; Wakimoto Y; Tanaka Y
Rinsho Byori; 2013 Sep; 61(9):787-94. PubMed ID: 24369590
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of HBsAg by Lumipulse HBsAg-HQ: The agreement with HBsAg by Architect HBsAg-QT and the effectiveness in predicting liver tissue pathological states of chronic hepatitis B patients.
Zhang Z; Ding R; Lu W; Yang Z; Wang Y; Zhou X; Huang D; Li X; Feng Y
Adv Clin Exp Med; 2018 Aug; 27(8):1045-1054. PubMed ID: 29893514
[TBL] [Abstract][Full Text] [Related]
7. The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen.
Yang R; Song G; Guan W; Wang Q; Liu Y; Wei L
J Virol Methods; 2016 Feb; 228():39-47. PubMed ID: 26615803
[TBL] [Abstract][Full Text] [Related]
8. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
[TBL] [Abstract][Full Text] [Related]
9. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the clinical performance of the ECLusys HBsAg II assay with the Lumipulse f and HISCL 2000-i HBsAg screening assays].
Sugiura A; Iwahara K; Suga Y; Uchiyama S; Maekawa M
Rinsho Byori; 2012 Feb; 60(2):103-9. PubMed ID: 22568090
[TBL] [Abstract][Full Text] [Related]
11. Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.
Minekawa T; Takehara S; Takahashi M; Okamoto H
Clin Vaccine Immunol; 2013 Aug; 20(8):1255-65. PubMed ID: 23761660
[TBL] [Abstract][Full Text] [Related]
12. An ultra-sensitive Abbott ARCHITECT
Lou S; Taylor R; Pearce S; Kuhns M; Leary T
J Clin Virol; 2018 Aug; 105():18-25. PubMed ID: 29843004
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial and performance evaluation of the Wantai HBsAg (CMIA) diagnostic kit for screening blood donors in China.
Chen J; Wang F; Li J; Zuo Q; Wu D; Xiao C
Sci Rep; 2024 Feb; 14(1):1891. PubMed ID: 38307913
[TBL] [Abstract][Full Text] [Related]
14. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes.
Scheiblauer H; El-Nageh M; Diaz S; Nick S; Zeichhardt H; Grunert HP; Prince A
Vox Sang; 2010 Apr; 98(3 Pt 2):403-14. PubMed ID: 20412171
[TBL] [Abstract][Full Text] [Related]
15. Early detection of hepatitis B surface antigen--prototype of a new fully automated HBsAg microparticle enzyme immunoassay (MEIA).
Pfeifer K; Pelzer C; Coleman P; Pope M; Kapprell HP
Clin Lab; 2003; 49(3-4):161-6. PubMed ID: 12705699
[TBL] [Abstract][Full Text] [Related]
16. Improved detection of hepatitis B virus surface antigen by a new rapid automated assay.
Weber B; Bayer A; Kirch P; Schlüter V; Schlieper D; Melchior W
J Clin Microbiol; 1999 Aug; 37(8):2639-47. PubMed ID: 10405414
[TBL] [Abstract][Full Text] [Related]
17. Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.
Shinkai N; Kusumoto S; Murakami S; Ogawa S; Ri M; Matsui T; Tamori A; Toyoda H; Ishida T; Iida S; Tanaka Y
Liver Int; 2017 Aug; 37(8):1138-1147. PubMed ID: 27992664
[TBL] [Abstract][Full Text] [Related]
18. [Performance Utility of High Sensitivity Quantitative Assay for HBs Antigen].
Sato I; Uto K; Fukuzumi N; Kitaaki S; Watanabe Y; Sakurai K; Ishida N; Oyabu C; Nakamachi Y; Hayashi N; Saegusa J
Rinsho Byori; 2017 Mar; 65(3):245-251. PubMed ID: 30802006
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of a novel HBsAg quantitative assay].
Takagi K; Tanaka Y; Naganuma H; Hiramatsu K; Iida T; Takasaka Y; Mizokami M
Rinsho Byori; 2007 Jul; 55(7):619-25. PubMed ID: 17718057
[TBL] [Abstract][Full Text] [Related]
20. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
